久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

歐司美特 Osteometer MediTech
骨質(zhì)疏松癥是一種會使30-40%的婦女在她們有生之年面臨骨質(zhì)疏松性骨折危險的疾病,這種風(fēng)險在男性,大約在13%*.

歐司美特 (Osteometer MediTech) 公司致力于提供一種客戶買得起的,高質(zhì)量的,可用于普通門診室,診斷骨質(zhì)疏松癥的骨密度儀,自第一臺機器離開工廠,十多年來我們已賣出了數(shù)千臺骨密度儀,今天, 歐司美特 (Osteometer MediTech) 公司已經(jīng)是全球范圍內(nèi)數(shù)個國家的門診室骨密度儀市場的領(lǐng)導(dǎo)者.

高品質(zhì)和高可靠性是歐司美特 (Osteometer MediTech) 公司的核心因素,從研發(fā)到生產(chǎn), 歐司美特 (Osteometer MediTech) 公司嚴(yán)格遵從下列標(biāo)準(zhǔn):

IEC 60601-1-2 Medical Electrical Equipment
The Medical Device Directive (93/42/EEC)
ISO 13485:2003(E)
另外, 歐司美特 (Osteometer MediTech) 公司的產(chǎn)品還遵從(FDA),CFR Part 21, Title 820(GMP).

作為骨質(zhì)疏松癥診斷產(chǎn)品市場的主要成員,歐司美特 (Osteometer MediTech) 公司,承諾致力于開發(fā)和生產(chǎn)科技含量高,臨床又歡迎的骨密度產(chǎn)品.實踐也已證明,我們的產(chǎn)品精確度準(zhǔn)確率具佳,可靠性好,性價比高,使盡量多的病人接受檢測成為可能.

Osteoporosis is a disease that gives women a risk of 30-40% of having an osteoporotic fracture in their lifetime. The lifetime risk for men is approximately 13%.*

Osteometer MediTech's focus is on offering affordable, high quality office based scanners and densitometers for diagnosis of osteoporosis. Since the first densitometer left the factory more than ten years ago, several thousand densitometers have followed, and today Osteometer MediTech is the market leader in office based densitometry in several countries around the globe.

Quality and reliability are key elements for Osteometer MediTech. From development to manufacturing, Osteometer MediTech complies with the following standards:

IEC 60601-1-2 Medical Electrical Equipment (General requirements for safety)
The Medical Device Directive (93/42/EEC)
ISO 13485: 2003 (E)
Furthermore, Osteometer's products are in compliance with the Food, Drug and Cosmetic Act (FDA), CFR Part 21, Title 820 (GMP).

Being one of the main market players within diagnosis of osteoporosis, Osteometer MediTech is committed to developing scientifically and clinically validated devices. This has resulted in accurate, precise, reliable and cost-effective scanners, making the diagnostic test accessible to as many patients as possible.